| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-408 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
| filingDate |
2000-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d233c38fcf5bcb6087c62665363a5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4044a6468a75b29a985af69c0ca788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06eef3664ffd8a0bfde414d73233892e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_320f8946cf1345d4aec12fa8e44e97b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31b0450ae7425a8fbf8e669746f3b571 |
| publicationDate |
2004-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6812344-B1 |
| titleOfInvention |
1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| abstract |
The present invention relates to certain novel piperazine derivatives having protracted uro-selective alpha1-adrenoceptor antagonistic activity exceeding those of previously described compounds. The compounds of the present invention hold promise for treating benign prostatic hyperplasia (BPH). This invention also relates to methods for making the novel compounds, pharmaceutical compositions containing the compounds, and methods of treating benign prostatic hyperplasia using the compounds. |
| priorityDate |
1997-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |